论文部分内容阅读
Infectiousbonedefectremainsaseriouscomplicatedchallengeincurrentorthopaedicsurgery.Fortreatmentoflargebone defectedcombinedwithintractableinfection,thelocaluseofantibiotic-loadedpolymethylmethacrylate(PMMA)bonecements,includinggentamicinandhydroxypropyltrimethylammoniumchloridechitosan(HACC),areinsufficientforbonerepair.Astherapeuticagentsaredesirableforenhancementofantibacterialandosteogenicactivity,thisstudywasdesignedtodevelop sucha3Dprintedbioactiveporousscaffold(PLGA/10%HA/HACC)madeofpolylactide-co-glycolide(PLGA)andhydroxyapatite(HA)(weightratio,PLGA:HA=9:1)asfundamentalcarrier,graftingwithHACCwitha22%degreeofsubstitution.PLGA,PLGA/10%HAandPLGA/HACCscaffoldswerealsoinvestigatedandcompared.Threestandardstrains,Staphylococcusaureus(ATCC25923), Staphylococcusepidermidis(ATCC35984)andmethicillin-resistantStaphylococcusaureus(ATCC43300),andoneclinicalisolates, methicillin-resistantS.epidermidis(MRSE287),wereselectedtoevaluatedthebacterialadhesionandbiofilmformationat4,24and48husingthespreadplatemethod,tissuecultureplate(TCP)methodandconfocallaserscanningmicroscopy(CLSM)in vitro.WefoundthatPLGA/10%HA/HACCandPLGA/HACCcompositescaffoldscouldsignificantlyinhibitbacterialadhesionand biofilmformationcomparedtoPLGAandPLGA/10%HAscaffolds,andscaffoldscontainHAshowedrelativehigherbacterialadhesiontosomeextent.Meanwhile,humanmarrowderivedmesenchymalstemcellswereusedtoassesstheosteogenicandrecruitmentactivityofcombinedapplicationofHAandHACCinPLGAscaffold.OurefficacystudyshowedthatPLGA/10%HAand PLGA/10%HA/HACCscaffoldsdemonstratedsignificantlypromotedcellattachment,proliferation,spreading,osteogenicdifferentiationandmigrationwhencomapredtothePLGAandPLGA/HACCscaffolds.Furthermore,aninvivodorsum subcutaneousembeddingmodelinSDratsusingabioluminescentS.aureus(ATCC12600,Xen29)wasalsoestablishedforrealtime monitoringofbacterialinfectionbytheIVISImagingSystem.TheinvivoobservationshowedanevidentdecreaseinbothluminescenceandbacterialcountsandunconspicuoussubcutaneousabscessinthegroupsofPLGA/10%HA/HACCandPLGA/HACCcomparedtotheothertwogroups.Ingeneral,thesefindingsmaydevelopagoodfoundationforpotentialclinicalvalidationofthisinovativebioactiveporousscaffoldforcombatinginfectiousbonedefect.